Trial Outcomes & Findings for A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne. (NCT NCT02698436)

NCT ID: NCT02698436

Last Updated: 2018-01-23

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

103 participants

Primary outcome timeframe

Baseline to 12 Weeks

Results posted on

2018-01-23

Participant Flow

Participant milestones

Participant milestones
Measure
Acne Mask
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
Benzoyl Peroxide 2.5%
Apply test product to face once in the morning and once at night.
Overall Study
STARTED
59
58
Overall Study
COMPLETED
52
51
Overall Study
NOT COMPLETED
7
7

Reasons for withdrawal

Reasons for withdrawal
Measure
Acne Mask
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
Benzoyl Peroxide 2.5%
Apply test product to face once in the morning and once at night.
Overall Study
Adverse Event
1
0
Overall Study
Withdrawal by Subject
3
3
Overall Study
Lost to Follow-up
2
4
Overall Study
Non-compliance with study regimen
1
0

Baseline Characteristics

A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Acne Mask
n=59 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide Treatment
n=58 Participants
Applied BPO treatment once daily
Total
n=117 Participants
Total of all reporting groups
Age, Continuous
17.8 years
STANDARD_DEVIATION 5.79 • n=5 Participants
18.7 years
STANDARD_DEVIATION 5.97 • n=7 Participants
18.2 years
STANDARD_DEVIATION 5.87 • n=5 Participants
Sex: Female, Male
Female
31 Participants
n=5 Participants
31 Participants
n=7 Participants
62 Participants
n=5 Participants
Sex: Female, Male
Male
28 Participants
n=5 Participants
27 Participants
n=7 Participants
55 Participants
n=5 Participants
Region of Enrollment
USA
59 participants
n=5 Participants
58 participants
n=7 Participants
117 participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline to 12 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Outcome measures

Outcome measures
Measure
Acne Mask
n=55 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Percent Change of Global Face Total Acne Lesion Count From Baseline
-44 Percent change of acne lesion count
Interval -51.0 to -37.0
-54 Percent change of acne lesion count
Interval -61.0 to -45.0

SECONDARY outcome

Timeframe: Baseline to 1 Week

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Outcome measures

Outcome measures
Measure
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 1
-19 Percent change of acne lesion count
Interval -25.0 to -13.0
-26 Percent change of acne lesion count
Interval -33.0 to -19.0

SECONDARY outcome

Timeframe: Baseline to 2 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Outcome measures

Outcome measures
Measure
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 2
-28 Percent change of acne lesion count
Interval -35.0 to -21.0
-42 Percent change of acne lesion count
Interval -48.0 to -35.0

SECONDARY outcome

Timeframe: Baseline to 4 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Outcome measures

Outcome measures
Measure
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 4
-35 Percent change of acne lesion count
Interval -42.0 to -27.0
-46 Percent change of acne lesion count
Interval -53.0 to -39.0

SECONDARY outcome

Timeframe: Baseline to 8 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Outcome measures

Outcome measures
Measure
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=51 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 8
-40 Percent change of acne lesion count
Interval -46.0 to -33.0
-50 Percent change of acne lesion count
Interval -62.0 to -38.0

SECONDARY outcome

Timeframe: Baseline

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Acne Lesion Count Total Global Face at Baseline

Outcome measures

Outcome measures
Measure
Acne Mask
n=55 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Acne Lesion Counts Total Global Face - Baseline
47.2 Lesion Count
Standard Deviation 22.56
47.6 Lesion Count
Standard Deviation 23.22

SECONDARY outcome

Timeframe: 1 Week

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Acne Lesion Count Total Global Face Week 1

Outcome measures

Outcome measures
Measure
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Acne Lesion Counts Total Global Face - Week 1
39.2 Lesion Count
Standard Deviation 22.5
36.8 Lesion Count
Standard Deviation 24.00

SECONDARY outcome

Timeframe: 2 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Acne Lesion Count Total Global Face Week 2

Outcome measures

Outcome measures
Measure
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Acne Lesion Counts Total Global Face - Week 2
35.3 Lesion Count
Standard Deviation 20.13
30.5 Lesion Count
Standard Deviation 22.88

SECONDARY outcome

Timeframe: 4 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Acne Lesion Count Total Global Face Week 4

Outcome measures

Outcome measures
Measure
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Acne Lesion Counts Total Global Face - Week 4
30.5 Lesion Count
Standard Deviation 17.51
27.0 Lesion Count
Standard Deviation 19.76

SECONDARY outcome

Timeframe: 8 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Acne Lesion Count Total Global Face Week 8

Outcome measures

Outcome measures
Measure
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=51 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Acne Lesion Counts Total Global Face - Week 8
27.8 Lesion Count
Standard Deviation 16.06
26.4 Lesion Count
Standard Deviation 28.40

SECONDARY outcome

Timeframe: 12 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Acne Lesion Count Total Global Face Week 12

Outcome measures

Outcome measures
Measure
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=51 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Acne Lesion Counts Total Global Face - Week 12
24.8 Lesion Count
Standard Deviation 15.76
23.3 Lesion Count
Standard Deviation 20.91

SECONDARY outcome

Timeframe: Baseline

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.

Outcome measures

Outcome measures
Measure
Acne Mask
n=55 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Investigator Global Acne Assessment - Baseline
2.55 Score on a scale
Standard Deviation 0.529
2.51 Score on a scale
Standard Deviation 0.471

SECONDARY outcome

Timeframe: 1 Week

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.

Outcome measures

Outcome measures
Measure
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=54 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Investigator Global Acne Assessment - Week 1
2.35 Score on a scale
Standard Deviation 0.538
2.34 Score on a scale
Standard Deviation 0.548

SECONDARY outcome

Timeframe: 2 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.

Outcome measures

Outcome measures
Measure
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Investigator Global Acne Assessment - Week 2
2.23 Score on a scale
Standard Deviation 0.598
2.11 Score on a scale
Standard Deviation 0.605

SECONDARY outcome

Timeframe: 4 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.

Outcome measures

Outcome measures
Measure
Acne Mask
n=54 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=52 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Investigator Global Acne Assessment - Week 4
2.08 Score on a scale
Standard Deviation 0.612
1.87 Score on a scale
Standard Deviation 0.650

SECONDARY outcome

Timeframe: 8 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.

Outcome measures

Outcome measures
Measure
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=51 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Investigator Global Acne Assessment - Week 8
1.88 Score on a scale
Standard Deviation 0.583
1.70 Score on a scale
Standard Deviation 0.775

SECONDARY outcome

Timeframe: 12 Weeks

Population: Includes all subjects who had measurements taken at this time point. Some subjects may have missed the visit, or had a protocol deviation that would exclude their data.

Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. 1. Almost Clear. A few scattered comedones and a few (less than five) small papules. 2. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. 3. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. 4. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. 5. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.

Outcome measures

Outcome measures
Measure
Acne Mask
n=52 Participants
Light therapy mask applied to the face once in the evening for a duration of 10 minutes
2.5% Benzoyl Peroxide
n=51 Participants
Both 2.5% BPO cleanser and treatment are applied twice daily, once in the moring and once in the evening
Investigator Global Acne Assessment - Week 12
1.77 Score on a scale
Standard Deviation 0.660
1.59 Score on a scale
Standard Deviation 0.726

Adverse Events

Acne Mask

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

2.5% Benzoyl Peroxide Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Lisa Fitzgerald

JNJWorldwide

Phone: +1 908-904-6235

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place